Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1999 May;91(5):262–264.

Prolactin response to the severity of surgical insult.

S Peter 1, A Bozorgzadeh 1, H Lamaute 1, S Preola 1, A Cooper 1, W Pizzi 1
PMCID: PMC2608493  PMID: 10365547

Abstract

Prolactin levels are elevated significantly during the recovery process from surgical insult, implying a role for prolactin in the neuroendocrine immune network. This study examined the importance of severity of surgical insult to the prolactin response. Two groups of surgical patients were chosen consecutively and studied prospectively. Seven patients scheduled for "clean" elective surgery, i.e., herniorrhaphy and laparoscopic cholecystectomy, were compared with seven patients scheduled for prolonged abdominal exploration. Blood was drawn for prolactin and cortisol at 8:00 AM on the day of surgery and on postoperative days one, three, and five. Using a two-tailed test, preoperative prolactin levels and levels on postoperative days three and five were significantly different in the prolonged surgery group (.012 and .002, respectively). There were no statistically significant differences in preoperative and postoperative prolactin levels in the clean surgery group. Cortisol levels were not significantly elevated in either group. These results indicate that the prolactin response to surgery is related to the severity of the surgical insult.

Full text

PDF
262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carrier M., Russell D. H., Cork R. C., Wild J., Emery R. W., Copeland J. G. Analysis of risk factors for acute allograft rejection after heart transplantation. J Heart Transplant. 1990 Jul-Aug;9(4):372–375. [PubMed] [Google Scholar]
  2. Carrier M., Wild J., Pelletier L. C., Copeland J. G. Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. Ann Thorac Surg. 1990 Jan;49(1):129–132. doi: 10.1016/0003-4975(90)90370-l. [DOI] [PubMed] [Google Scholar]
  3. Nagy E., Berczi I., Friesen H. G. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 1983 Mar;102(3):351–357. doi: 10.1530/acta.0.1020351. [DOI] [PubMed] [Google Scholar]
  4. Nagy E., Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 1978 Nov;89(3):530–537. doi: 10.1530/acta.0.0890530. [DOI] [PubMed] [Google Scholar]
  5. Nagy E., Berczi I., Wren G. E., Asa S. L., Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology. 1983 Oct;6(3):231–243. doi: 10.1016/0162-3109(83)90023-1. [DOI] [PubMed] [Google Scholar]
  6. Reber P. M. Prolactin and immunomodulation. Am J Med. 1993 Dec;95(6):637–644. doi: 10.1016/0002-9343(93)90360-2. [DOI] [PubMed] [Google Scholar]
  7. Russell D. H., Matrisian L., Kibler R., Larson D. F., Poulos B., Magun B. E. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun. 1984 Jun 29;121(3):899–906. doi: 10.1016/0006-291x(84)90762-9. [DOI] [PubMed] [Google Scholar]
  8. Yongjin J., ZiLin F., Zhenmei B. Bromocriptine as an adjuvant to cyclosporine immunosuppression after renal transplantation. Transplant Proc. 1997 Feb-Mar;29(1-2):297–297. doi: 10.1016/s0041-1345(96)00115-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES